Follow The Filings

TECH Bio-Techne Corporation

Health Care, filed as BIO-TECHNE CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 5

  • 8 Owners
  • #163
  • Max 3.7%
  • Master 0.04%
  • $652M
  • 1 new 5 reduce 2 small

In 2026 Q2, 1 manager opened a position and 5 trimmed.

Who owns this now

Largest portfolio weights among holders, up to 3.7% (Ruane, Cunniff & Goldfarb). Not free-float ownership.

  1. Ruane, Cunniff & Goldfarb Reduce 3.7%
  2. Wallace Weitz Reduce 2.7%
  3. Mairs & Power Reduce 1.8%
  4. Lee Ainslie Reduce 0.96%
  5. George Soros New 0.46%
  6. Henry Ellenbogen Reduce 0.34%

Who owns TECH

Sorted by value, long equity only, as of 2026 Q2.

History
Ruane, Cunniff & Goldfarb 3.7% Small trim −1.3% 3,348,841 $237M History
Mairs & Power 1.8% Small trim −1.8% 2,700,698 $191M History
Lee Ainslie, Maverick Capital 0.96%, was 2.9% Reduce −67.6% 1,535,610 $108M History
Wallace Weitz, Weitz Investment Management 2.7% Reduce −16.8% 543,200 $38M History
George Soros, Soros Fund Management 0.46% New 0.46% 535,400 $38M History
Henry Ellenbogen, Durable Capital Partners 0.34%, was 2.4% Reduce −88.7% 501,963 $35M History
Glenview Capital Management 0.08%, was 0.25% Reduce −68.7% 58,324 $4.1M History
Ron Baron, Bamco Inc. (Baron Capital) <0.01%, was 0.09% Reduce −99.7% 1,800 $127K History

8 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TECH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TECH insider trades
  • None no insider bought on the open market
  • $437K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Amy E. Herr Director
    Sale
    $320K 6,636 shares at $48.28 97% of stake
    Traded May 8 Filed May 12
    ↗
  2. Amy E. Herr Director
    Sale
    $117K 1,976 shares at $59.11 91% of stake
    Traded Feb 17 Filed Feb 19
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises and 25 share withholdings for taxes.

Congress

3 members of Congress traded TECH in the last three years: 6 buys and 8 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $1K–$15K Apr 8 filed May 6
  2. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Mar 26 filed Apr 6
  3. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Feb 24 filed Mar 10
  4. April McClain Delaney D-MD-6Child Partial sale $1K–$15K Jan 28 filed Feb 2
  5. April McClain Delaney D-MD-6Child Buy $1K–$15K Dec 5, 2025 filed Jan 5
  6. April McClain Delaney D-MD-6Child Buy $1K–$15K Dec 2, 2025 filed Jan 5

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
10-K/A Filing Doc
8-K 5.07,7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A SOLICITING MATERIAL Filing Doc
8-K 1.01,5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
DEFA14A SOLICITING MATERIAL Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $1.14B $1.16B $1.22B $1.22B
Gross profit $769.82M $769.72M $790.27M $799.07M
Gross margin * 67.7% 66.4% 64.8% 65.8%
Net income $285.26M $168.1M $73.4M —
Net margin * 25.1% 14.5% 6.0% —

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $621.48M $617.42M $608.3M $744.4M
Total non-current assets * $2.02B $2.09B $1.95B $1.84B
Total assets $2.64B $2.7B $2.56B $2.59B
Total current liabilities $128.51M $159.38M $175.85M $163.7M
Total equity $1.97B $2.07B — $2.11B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $254.39M $298.98M $287.56M $292.07M
Cash from investing -$265.65M -$203.03M -$35.18M -$18.19M
Cash from financing $22.62M -$122.4M -$253.9M -$169.11M
Net change in cash $8M -$28.78M $10.4M $102.53M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.